About us
Coriolis pharma - outstanding biopharmaceutical research
Coriolis is a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs and vaccines. Founded in 2008, Coriolis is the expert for biopharmaceutical development of liquid and lyophilized drug products, including lyophilization process development and analytical services. We have supported the successful development of many drug products and our scientists are eager to apply their experience to your project.
Our mission
Our motivation is to enable the development of innovative drugs by performing outstanding biopharmaceutical research to improve the quality of life for humankind.
Our vision
We enable innovative therapies by revolutionizing formulation development.
We revolutionize the development process of biopharmaceutical drugs by integrating innovative digital formulation approaches from drug development to commercial products. We thereby enable future therapies to be made available to humankind efficiently and on time.
Our strategy
Formulating innovation
For us innovation is progress achieved by collaboration. We generate innovation by combining technologies, knowledge and experience. Formulating for us means: to find the right solution.
Our facts & figures
Foundation of Coriolis Pharma
Move to the IZB (Innovation and Start-Up Center for Biotechnology) in Martinsried
GMP accreditation
Biological Safety Level (BSL) 1 & 2 certification
Move to new facilities in Martinsried
10th anniversary of Coriolis Pharma
Expansion into new facilities for ATMP development (up to BSL2)
Your partner with scientific excellence
From discovery phase to and beyond market approval, Coriolis provides high-quality research, development, and analytical services. Our strategy is to generate innovation by combining technologies, knowledge, and experience. In collaborative partnership with our clients, we develop innovative drugs to improve the quality of life for humankind.
Let's talk!
Click on a topic to contact our experts
Dr. Stefan Heindl
Phone: +49 89 41 77 60 – 114
Mail: stefan.heindl@coriolis-pharma.com
Dr. Matthias Lucke
Phone: +49 89 41 77 60 – 253
Mail: matthias.lucke@coriolis-pharma.com
Dr. Jörg Müller
Phone: +49 89 41 77 60 – 111
Mail: joerg.mueller@coriolis-pharma.com
Dr. Anja Bürger
Phone: +49 89 41 77 60 – 259
Mail: anja.buerger@coriolis-pharma.com
Dr. Stefan Heindl
Phone: +49 89 41 77 60 – 114
Mail: stefan.heindl@coriolis-pharma.com
Ana Rother
Coriolis Pharma Research GmbH
Biopharmaceutical Research and Development Service
Fraunhoferstraße 18 b
82152 Martinsried
Germany
Phone: +49 89 41 77 60 – 0
Fax: +49 89 41 77 60 – 222
Follow us on Social Media
